Tuesday, July 13, 2021 8:24:38 PM
CUBT thanks oxnous! Thanks for sharing this factual DD.
I really do not understand WHY there is any confusion about facts.
If one can read and understand filings an investor can see that the current management of CUBT purchased convertible preferred shares from previous management (CTYX at the time). There was NO GIFTING of shares. The convertible preferred shares were already in existence, purchased from the CTYX holders (past CEO's) and then they were VESTED...not converted, in November. Converted, finally, in May.
Next indisputable fact:
Twelve (12) months AFTER the company becomes Fully Reporting (which the required Form 10 filing is considered to be "imminent") the insiders can begin selling at a maximum rate of 1% of the shares outstanding in every 90 day period. If they want to sell at that time.
There can be a "belief" that the facts are not correct, but the facts are...factual.
I really do not understand WHY there is any confusion about facts.
If one can read and understand filings an investor can see that the current management of CUBT purchased convertible preferred shares from previous management (CTYX at the time). There was NO GIFTING of shares. The convertible preferred shares were already in existence, purchased from the CTYX holders (past CEO's) and then they were VESTED...not converted, in November. Converted, finally, in May.
Next indisputable fact:
Twelve (12) months AFTER the company becomes Fully Reporting (which the required Form 10 filing is considered to be "imminent") the insiders can begin selling at a maximum rate of 1% of the shares outstanding in every 90 day period. If they want to sell at that time.
There can be a "belief" that the facts are not correct, but the facts are...factual.
Recent CUBT News
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 05/09/2025 07:00:02 PM

